These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2503937)

  • 1. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens.
    van Rhenen DJ; Thijssen PM; Overbeeke MA
    Vox Sang; 1989; 56(4):274-7. PubMed ID: 2503937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens by the Federation of Netherlands Red Cross Blood Banks.
    van Rhenen DJ; Overbeeke MA
    Vox Sang; 1989; 57(4):273-4. PubMed ID: 2515656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on detection of samples of Rh-weak D and Del].
    Wang XZ; Lan JC; Wu XH; Zhou HY; Liu WJ; Liu D; Qi CS; Zeng FQ; Du KQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):509-11. PubMed ID: 15972154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents.
    Kumpel BM; Poole GD; Bradley BA
    Br J Haematol; 1989 Jan; 71(1):125-9. PubMed ID: 2492817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expediency of typing rhesus-negative donor blood samples using sera containing anti-Rh''(E) antibodies].
    Mikhaĭlova AA; Kuznetsov KV
    Gematol Transfuziol; 1988 Nov; 33(11):53-5. PubMed ID: 3148486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Revised definition of the concept rhesus-negative blood donor; practical experiences].
    van Rhenen DJ; Overbeeke MA; Dudok de Wit C; Engelfriet CP
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1005-7. PubMed ID: 2112234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
    Garratty G; Petz LD
    Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens.
    Frame T; van de Kamp G; van Eijk RV
    Vox Sang; 1990; 58(3):232-3. PubMed ID: 2111066
    [No Abstract]   [Full Text] [Related]  

  • 10. The Rh-negative donor.
    Contreras M; Knight RC
    Clin Lab Haematol; 1989; 11(4):317-22. PubMed ID: 2514064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a solid-phase test for erythrocyte antibody screening of pregnant women, patients and blood donors.
    Sallander S; Shanwell A; Aqvist M
    Vox Sang; 1996; 71(4):221-5. PubMed ID: 8958646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies directed against human Rh antigens in tests with red cells of non-human primates.
    Blancher A; Socha WW; Roubinet F; Ruffié J
    Transfus Clin Biol; 1996; 3(6):339-45. PubMed ID: 9018786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies directed against human Rh antigens in tests with the red cells of nonhuman primates.
    Socha WW; Ruffie J
    Rev Fr Transfus Hemobiol; 1990 Jan; 33(1):39-48. PubMed ID: 2111136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the D, c, E and G antigens of the Rh blood group system with human monoclonal antibodies.
    Bloy C; Blanchard D; Lambin P; Goossens D; Rouger P; Salmon C; Masouredis SP; Cartron JP
    Mol Immunol; 1988 Sep; 25(9):925-30. PubMed ID: 2463484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak D antigen testing using the groupamatic system.
    Glackin KC; Sherwood WC; Hoppe PA; McIntyre K
    Vox Sang; 1984; 47(1):82-7. PubMed ID: 6429956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of 62 Rh MAbs with weak and variant antigens.
    Morelati F; Revelli N; Drago F; Mancuso P; Sirchia G
    Transfus Clin Biol; 1996; 3(6):359-66. PubMed ID: 9018789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial investigations of carriers of Rh 33].
    Endres W; Lichy S; Stangel W
    Beitr Infusionsther Transfusionsmed; 1994; 32():187-9. PubMed ID: 9480082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial deletion of the D antigen in a family group. Determination of its antigenic density by flow cytometry].
    Hernández T; León G; Sánchez P
    Sangre (Barc); 1994 Apr; 39(2):139-43. PubMed ID: 7520193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.